Case Reports
Cell-mediated immunity in patients with renal adenocarcinoma
- PMID: 61119
Item in Clipboard
Case Reports
Cell-mediated immunity in patients with renal adenocarcinoma
Eur Urol.
1975.
Abstract
The lymphocytotoxicity test was used to study the existence of immunologically active lymphocyte reactions in patients with renal carcinoma at different stages. In 9 patients with an advanced renal carcioma (stage IV) a low lymphocytotoxicity was found, while the examination of 7 patients with stage I and II renal tumours showed a high value of the lymphocytotoxicity test. The clinical importance of the lymphocytotoxicity test is discussed with special interest in a possible immunotherapy.
Similar articles
-
Immunologic evaluation of human renal cell carcinoma. In vitro studies.Invest Urol. 1975 Jul;13(1):60-6. Invest Urol. 1975. PMID: 49333
-
Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.J Urol. 1973 Jul;110(1):31-5. doi: 10.1016/s0022-5347(17)60105-8. J Urol. 1973. PMID: 4713354 No abstract available.
-
In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.J Urol. 1976 Mar;115(3):239-42. doi: 10.1016/s0022-5347(17)59154-5. J Urol. 1976. PMID: 1255882
-
Immunobiology of genitourinary tumors.Urology. 1973 Nov;2(5):485-92. doi: 10.1016/0090-4295(73)90553-0. Urology. 1973. PMID: 4358375 Review. No abstract available.
-
Proceedings: Current results from treatment of renal cell carcinoma.Proc Natl Cancer Conf. 1972;7:751-9. Proc Natl Cancer Conf. 1972. PMID: 4587662 Review. No abstract available.